Skip to main content
. 2022 Jun 29;10(4):e00247-22. doi: 10.1128/spectrum.00247-22

TABLE 1.

Genomic variations identified in representative clones of tobramycin and ceftazidime ALEs in urine, SCFM and rich medium

Clone Gene Genetic event Amino acid changea
TobU fusA 2011A→G Thr671Ala
orfK 355G→A Glu119Lys
nuoD 183_184insC Lys63fs
 
TobS ptsP 1135dupG Ala379fs
fusA 2038C→T Arg680Cys
orfH 286C→T Arg96*
 
TobRM ptsP 2156delG Glu677fs
fusA 1634G→A Gly545Asp
orfN 148delG Val50fs
pmrB 853G→C Val285Leu
 
CazU mpl 353C→G Thr118Ser
ftsL 176G→A Gly59Asp
 
CazS mpl 706A→C Thr236Pro
dacB 326G→A Gly109Asp
clpS 248A→C Gln83Pro
ftsI 1510C→T Arg504Cys
 
CazRM mpl 416T→G Val139Gly
dacB 343C→T Gly115Ser
nalD 32G→T Thr11Asn
pitA 367A→C Thr123Pro
del299,648 bp del3200274–3499932
 
Caz-AviU mpl 742C→T Gln248*
ftsL 176G→A Gly59Asp
 
Caz-AviS anmK 197G→A Trp66*
mpl 111delC Met38fs
mpl 104A→C Tyr35Ser
 
Caz-AviRM PA14_45890 1001G→A Ser334Leu
ftsI 1567C→T Val523Met
ftsI 1511C→T Arg504His
clpA 1634A→G Tyr545Cys
del220701 bp del3288650–3509351
a

An asterisk indicates the mutation led to a stop codon.